US2005106266A1PendingUtilityA1
Formulation for menopausal women
Priority: Sep 30, 1999Filed: Dec 22, 2004Published: May 19, 2005
Est. expirySep 30, 2019(expired)· nominal 20-yr term from priority
A61P 5/34A61P 5/30A61P 9/00A61P 3/02A61P 29/02A61P 25/24A61P 25/02A61P 25/20A61P 25/22A61P 15/00A61P 15/12A61P 21/00A61P 1/12A61P 1/10A61P 1/08A61P 19/02A61K 45/06A23V 2002/00A23L 33/15A23L 33/12A23L 33/16A61K 33/06
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from systems associated with menopause, as well as prophylactic effects, and methods for using same.
Claims
exact text as granted — not AI-modified1 . A composition for supplementing the diet, the composition comprising:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.
2 . A composition for administration to premenopausal and menopausal women, the composition comprising:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.
3 . A method for providing nutritional supplementation to a menopausal woman, which comprises:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.
4 . A method for providing nutritional supplementation to a premenopausal woman, which comprises:
a. docosahexaenoic acid in an amount of from about 10 mg to about 1000 mg; and b. a calcium compound present in an amount such that the ratio of docosahexaenoic acid to calcium compound is from about 1:0.4 to 1:250.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.